Summary: [170 Pages Report] Lewy Body Dementia
Treatment Market research report categorizes the global market by Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Carbidopa-Levodopa, Antidepressants, Benzodiazepine, Modafinil), By Indication (Dementia with Lewy Bodies, Parkinson's Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), & By Region (North America, Latin America, Europe, MEA, East Asia, South Asia, Oceania)
Lewy body dementia
is a disease associated with the abnormal deposits of a protein called alpha-synuclein in the brain.
Memorials to Lewy Body Dementia
Association, https://www.lbda.org/honor-memorials-gifts would be appreciated.
Increasing healthcare spending has the potential to directly impact the need for lewy body dementia
diagnostics and treatment solutions, which, in turn, will create growth opportunities for stakeholders in the market.
It was when Carole and Jean attended a course about the condition that Carole was advised to have her mum's health checked and Jean was subsequently diagnosed with Lewy Body dementia
Rodin's targeted approach to strengthening synaptic integrity, backed by a robust translational strategy, has potential across multiple diseases, such as Alzheimer's disease, Lewy body dementia
, Huntington's disease and frontotemporal dementia, all of which are characterized by impaired neuronal and synaptic function.
Robin took his own life in 2014, at the age of 63, while suffering from the little-known Lewy body dementia
The 69-year-old had been battling Lewy body dementia
, which is the second most common type of the disease after Alzheimer's.
When someone is given a diagnosis of dementia it means they have a deteriorating disease of the brain such as Alzheimer's, vascular dementia, Lewy body dementia
or frontotemporal dementia.
For example, fluctuating attention, visual-spatial impairments, and some mood/behavior disturbances (delusions, hallucinations) are more likely to occur with Lewy body dementia
. Conversely, deficits in episodic memory (your recollection of personal experiences from your past) and short-term memory may be early symptoms of Alzheimer's disease, and also can indicate the progression of mild cognitive impairment (mild memory issues that can be a precursor for Alzheimer's disease).
Recent in-vitro and cell culture research have shown the ability to stop the propagation and seeding of a-synuclein aggregates against increased monomeric alpha-synuclein expression, fibril preparations of seeded alpha-synuclein, and alpha-synuclein seeds derived from patients diagnosed with Parkinson's disease or Lewy Body Dementia
. Seelos will evaluate the potential for in-vivo delivery of SLS-007 in a PD transgenic mice model.